Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-17-202485
Filing Date
2017-06-13
Accepted
2017-06-13 16:27:36
Documents
3
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d382572d10qa.htm 10-Q/A 64722
2 EX-31.1 d382572dex311.htm EX-31.1 8855
3 EX-31.2 d382572dex312.htm EX-31.2 8813
  Complete submission text file 0001193125-17-202485.txt   83461
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36395 | Film No.: 17909163
SIC: 2834 Pharmaceutical Preparations